New in JAMA Psychiatry with Emmanuel Greenberg, Susan Busch Marissa King

jamanetwork.com/journals/jamap…

We meticulously identified 1800+ private equity-owned outpatient mental health and substance use treatment clinics from 2012-2023.

MA markets with larger benchmark cuts absorbed the cuts without shrinking the MA market, suggesting that insurers maintained benefits valued by marginal enrollees.

See the full paper + editorial for more:
Editorial: jamanetwork.com/journals/jama-…
Paper: jamanetwork.com/journals/jama-…
(5/5)

Looking forward to presenting our new findings at #ASCO24 !
How much industry money do NCI cancer centers receive, relative to public/NCI funding? 🤔

Looking forward to presenting findings on differences in cancer treatment between Medicare Advantage and Medicare FFS patients, with JeahJung & co on the team! #ASCO24

I'm really looking forward to this talk!
Signup in the linked tweet.
(east coasters, note the GMT time zone!)

Anna Kaltenboeck Tim Anderson Audrey D. Zhang (@audreydzhang.bsky.social) Dan hartung Colleen Carey Kosuke Inoue Yusuke Tsugawa Jing Li 李婧 JeahJung Stacie Dusetzina Genevieve Kanter, PhD

How do Medicare outcomes differ among racial and ethnic groups? @JeanKJung of George Mason University +coauthors explore differences in quality-of-care outcomes in Medicare and MA between minority and non-Hispanic White populations. Read the full study: bit.ly/4cp27Xo

Excited to host Michael Anne Kyle at Memorial Sloan Kettering Cancer Center! Discussing this recent work on prior authorization, subject of my quoted tweet below.

(MSK peeps who want to attend in person, email me!)

How much money does #Medicare waste each year on guideline-discordant bone therapy for prostate cancer?

Our answer, reported this week in JCO Oncology Practice:
$43 million per year

Even in the health care world, that ain't pocket change.
ascopubs.org/doi/10.1200/OP…
🧵
1/

A holiday season publication! We find that infliximab and filgrastim biosimilar uptake from 2017-2019 is consistently higher in MA compared to TM, and that Kaiser HMO plans drive those differences. Mariana Socal Kelly Anderson, Andrew Xuan, & Jerry Anderson

jmcp.org/doi/full/10.18…

Future oncology health services researchers -
Great new opportunity for protected research time while working at the world's greatest cancer center!
Put this post-doc at Memorial Sloan Kettering Cancer Center on your radar!

Pharmacy Benefit Managers ( #PBM ): How did they emerge? What do they do? How should we evaluate policy proposals that regulate them?

Ge Bai, David Hyman, & I discuss in JAMA Health Forum

(Thread 12/12)

jamanetwork.com/journals/jama-…

Did you know hospitalization and ER visit rates differ quite a bit among home- and community-based service vs nursing facility service users, depending on where you live?

For more information, read our paper: journals.sagepub.com/doi/10.1177/10…

#LTC #aging #Medicaid

Coverage of our recent The BMJ study in HealthDay News news:

physiciansweekly.com/industry-payme…

Read about the wide variation in resource use differences between #Medicare Advantage and traditional #Medicare in a new paper published this month from JeahJung of George Mason University + coauthors. bit.ly/464zH18

New paper in Health Affairs with Yang Wang, Jianhui (Frank) Xu, Ge Bai, and Gerard Anderson.

In this paper, we study differences in hospital prices in commercial vs. Medicare Advantage within the same hospital and insurer. #PriceTransparency

🧵below:

healthaffairs.org/doi/10.1377/hl…

Why are cancer drugs so much more expensive than other classes? Any why are their prices increasing so much faster in the US vs. other countries?

Glad to have been part of this recent study with miquel serra-burriel Kerstin Noëlle Vokinger in eClinicalMedicine – The Lancet Discovery Science
sciencedirect.com/science/articl…

Want to learn about Medicare Advantage?

Come find these 3 health economists at the top of Lion’s Head!

Attending #IHEA23 this morning? Grab a cup of coffee and come join me in Nerina for 3 great presentations on Big Data Approaches to Strengthening Health Financing from JeahJung Vishalie Shah & Michel Oskam

🚨🚨🚨
Our new ASCO #ASCO23 abstract released today asks a novel question:
'Can receiving drug industry 💰 lead doctors to provide WORSE care?'

🧵 to follow
meetings.asco.org/abstracts-pres…
1/

Great exposé of the Medicare Advantage grift. Any wonder that the 'hottest' heath care startups are just fancy MA plans?

Fraud in MA could be as large as the budget of the FBI, EPA and federal prison system combined.

thanks Margot Sanger-Katz Reed Abelson

nytimes.com/2022/10/08/ups…